Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy-Reference-Cited by-同舟云学术

Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy

Published:2020-09-04 Issue:4 Volume:62 Page:486-492
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Valkema Maria J.,van der Wilk Berend J.,Eyck Ben M.,Wijnhoven Bas P.L.,Spaander Manon C.W.,Doukas Michail,Lagarde Sjoerd M.,Schreurs Wendy M.J.,Roef Mark J.,van Lanschot J. Jan B.,Valkema Roelf

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference23 articles.

1. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

2. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

3. Quality of life in patients with upper GI malignancies managed by a strategy of chemoradiotherapy alone versus surgery;O’Connell;Surg Oncol.,2019

4. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial;Noordman;Ann Oncol.,2018

5. Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial;Noordman;BMC Cancer.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [18F]FDG PET-CT radiomics signature to predict pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a multicenter study;European Radiology;2023-12-21

2. 18F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy;Nuclear Medicine Communications;2023-11-20

3. Clinical utility of [18F]FDG PET/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancer;European Radiology;2023-07-18

4. Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon;British Journal of Surgery;2023-07-07

5. Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions;Frontiers in Immunology;2023-05-30